SM

Sushma Manoj Kasliwal

Active Director Director DIN 10603371
DIN 10603371 First appointment Apr 2024 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushma Manoj Kasliwal

Data last updated:

Sushma Manoj Kasliwal is a Director at Anilkumar & Brothers Pharmaceuticles Private Limited (since 2024). The company operates in Chemicals.

DIN 10603371
Primary Designation Director
Industry Chemicals
First Appointment 24 Apr 2024
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Apr 20242022Active

Board colleagues of Sushma Manoj Kasliwal

Directorship timeline

Open interactive timeline →
Anilkumar & Brothers Pharmaceuticles Private Limited
Premium access

Shareholding and investment profile for Sushma Manoj Kasliwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushma Manoj Kasliwal

Sushma Manoj Kasliwal currently holds 1 directorship: Anilkumar & Brothers Pharmaceuticles Private Limited (Director, since 24 Apr 2024).

Sushma Manoj Kasliwal was first appointed on 24 Apr 2024 as Director at Anilkumar & Brothers Pharmaceuticles Private Limited.

The current boards of Sushma Manoj Kasliwal's companies include Hrishikesh Nilesh Totla (Anilkumar & Brothers Pharmaceuticles Private Limited), Manoj Jaykumar Kasliwal (Anilkumar & Brothers Pharmaceuticles Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available